Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Postoperative delirium : Part 2: detection, prevention and treatment
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 1197544
Author(s) Steiner, Luzius A
Author(s) at UniBasel Steiner, Luzius A.
Year 2011
Title Postoperative delirium : Part 2: detection, prevention and treatment
Journal European journal of anaesthesiology
Volume 28
Number 10
Pages 723-32
Keywords antipsychotics, benzodiazepines, cholinesterase inhibitors, delirium, dexmedetomidine, haloperidol, postoperative complications
Abstract To target pharmacological prevention, instruments giving an approximation of an individual patient's risk of developing postoperative delirium are available. In view of the variable clinical presentation, identifying patients in whom prophylaxis has failed (that is, who develop delirium) remains a challenge. Several bedside instruments are available for the routine ward and ICU setting. Several have been shown to have a high specificity and sensitivity when compared with the standard definitions according to DSM-IV-TR and ICD-10. The Confusion Assessment Method (CAM) and a version specifically developed for the intensive care setting (CAM-ICU) have emerged as a standard. However, alternatives allowing grading of the severity of delirium are also available. In many units, the approach to delirium follows a three-step strategy. Initially, non-pharmacological multicomponent strategies are used for primary prevention. As a second step, pharmacological prophylaxis may be added. Perioperative administration of haloperidol has been shown to reduce the severity, but not the incidence, of delirium. Perioperative administration of atypical antipsychotics has been shown to reduce the incidence of delirium in specific groups of patients. In patients with delirium, both symptomatic and causal treatment of delirium need to be considered. So far symptomatic treatment of delirium is primarily based on antipsychotics. Currently, cholinesterase inhibitors cannot be recommended and the data on dexmedetomidine are inconclusive. With the exception of alcohol-withdrawal delirium, there is no role for benzodiazepines in the treatment of delirium. It is unclear whether treating delirium prevents long-term sequelae.
Publisher Lippincott Williams & Wilkins
ISSN/ISBN 0265-0215
edoc-URL http://edoc.unibas.ch/dok/A6007699
Full Text on edoc No
Digital Object Identifier DOI 10.1097/EJA.0b013e328349b7db
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/21912241
ISI-Number WOS:000294800900006
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.342 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024